The leading representative office of defined VC is situated in the Stamford. The fund was located in North America if to be more exact in United States.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2011. This American Bailey Ventures works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2004. The fund is constantly included in less than 2 deals per year.
We can highlight the next thriving fund investment areas, such as Software, Pharmaceutical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Atlantis Components, Endocyte For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the American Bailey Ventures, startups are often financed by Sanderling Ventures, Triathlon Medical Venture Partners, Burrill & Company. The meaningful sponsors for the fund in investment in the same round are Sanderling Ventures, Triathlon Medical Venture Partners, Burrill & Company. In the next rounds fund is usually obtained by Triathlon Medical Venture Partners, Sanderling Ventures, Burrill & Company.
Related Funds
Funds with similar focus
Fund Name | Location |
Aishida | China, Wenling, Zhejiang |
CapitalX | California, San Francisco, United States |
Chongqing Chengxing Equity Investment Fund Partnership | - |
El Pais | Community of Madrid, Madrid, Spain |
Exclusive Ventures | Boulogne-Billancourt, France, Ile-de-France |
Founders Equity Partners | California, Palo Alto, United States |
Fuse Capital | Brazil, Rio de Janeiro, Rio De Janeiro |
Kli Capital | Canada, Montréal, Quebec |
Liangjie Touzi | China, Hangzhou, Zhejiang |
Octane Capital Management | California, Mountain View, United States |
Sensinnovat | - |
The Rose-Hulman Institute of Technology | Indiana, Terre Haute, United States |
Twangiza Transaction | - |
U.S. Army Combat Capabilities Development Command Army Research Laboratory | Louisiana, Maryland, United States |
U.S. International Development Finance Corp | District of Columbia, United States, Washington |
Venture Capital Action Plan | - |
WeDo Capital Management | Beijing, Beijing, China |
Weihe Investment | - |
Zhonghuijin Group | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Endocyte | $26M | 19 Jan 2010 | Indiana, United States | ||
Endocyte | $15M | 26 Mar 2007 | Indiana, United States | ||
Atlantis Components | $12M | 21 Sep 2004 | Cambridge, Massachusetts, United States | ||
Endocyte | $12M | 22 May 2003 | Indiana, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Endocyte | $26M | 19 Jan 2010 | Indiana, United States | ||
Endocyte | $15M | 26 Mar 2007 | Indiana, United States | ||
Atlantis Components | $12M | 21 Sep 2004 | Cambridge, Massachusetts, United States | ||
Endocyte | $12M | 22 May 2003 | Indiana, United States |